When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EPZM - FDA approves Epizyme's treatment for epithelioid sarcoma
Epizyme Inc.
Epizyme (NASDAQ:EPZM) says the Food and Drug Administration granted accelerated approval of its Tazverik (tazemetostat) treatment for the patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma, a rare, slow-growing type of cancer.
More news on: Epizyme, Inc., Healthcare stocks news,